Mometasone (as furoate monohydrate) 50mcg/spray; contains benzalkonium chloride. Not for treating asthma. Avoid use in patients with recent nasal ulcers, surgery, or injury that has not healed.

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

The spray, which is bioequivalent and therapeutically equivalent to the reference listed drug Nasonex nasal spray, 50 mcg, of Organon LLC, will be launched in the US market Q1FY25, Aurobindo said ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...